FDA Inspection
Cambrex Charles City, Inc.Cambrex Charles City, Inc. – FDA Inspection, Mar 7, 2025
Record Details
This FDA Inspection record concerns Cambrex Charles City, Inc., with an inspection on March 7, 2025, issued by the Kansas City District Office, covering human drugs.
View Company Profile
ID · bd4a48d6-1e7e-49c5-bf07-f30760432852
Inspection Facts
- Inspection number
- 1266564
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Cambrex Charles City, Inc.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| May 2, 2022 | VAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| December 22, 2016 | VAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| February 27, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 2, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 28, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Cambrex Charles City, Inc.
- FDA Inspection 1169072 - 2022-05-02
- FDA Inspection 1009802 - 2016-12-22
- FDA Inspection 868083 - 2014-02-27
- FDA Inspection 843001 - 2013-08-02
- FDA Inspection 768805 - 2012-02-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.